OTC Watch

All stocks / ACBM

ACRO BIOMEDICAL CO., LTD. ACBM

Acro Biomedical (ACBM): a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Late filingEstimated float Pink LimitedIndiana, USA
Live quote on OTC Markets

Market listing

Full name
ACRO BIOMEDICAL CO LTD
Market tier
OTC Pink Limited
Trading status
Active
Last trade
Aug 05
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$0
Net loss
($101,146)
What it means

It spends more than it earns

Under strain

The company lost $101,146 in the year. It reported no sales.

The report says
Cash and cash equivalents
$4,098
Net cash used in operating activities
($196,302)
What it means

The cash could run out soon

Under strain

It had $4,098 in the bank and used about $16,358 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$14,098
Total liabilities
$401,062
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $14,098. Its debts and unpaid bills add up to $401,062. That is about $28.45 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Late filing2026-11-16

Filed NT 10-Q on 2026-11-16: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Estimated float2026-08-05

Estimated float about 60,042,000 shares as of 2026-08-05: 60,042,000 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-09-30
60.0M
2025-11-10
60.0M
2025-12-31
60.0M
2026-01-31
60.0M
2026-03-31
60.0M
2026-04-28
60.0M
2026-06-30
60.0M
2026-08-05
60.0M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 NT 10-QNT 10-Q
2026-09-02 8-KFORM 8-K
2026-08-14 10-QFORM 10-Q
2026-05-05 10-QFORM 10-Q
2026-02-11 10-KFORM 10-K
2026-01-08 8-KFORM 8-K

Common questions about ACBM

Does ACBM file reports with the SEC?

Yes. Acro Biomedical files with the SEC under company number 0001622996. The most recent filing we hold is a NT 10-Q dated 2026-11-16.

Source record

How many ACBM shares are outstanding?

60,042,000 shares as of 2026-08-05, as reported to the SEC.

Source record

Has ACBM filed reports late?

Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-Q on 2026-11-16. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Acro Biomedical making money?

The company lost $101,146 in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record